Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Latest filing published 15 Jan 2020 for Audentes Therapeutics, Inc., €14.1M. Read the official filing
Filing timeline
BuySaleMatthew R. Patterson
Insider track record
Disclosed buys
0
Disclosed sells
23
Signal history
Matthew R. Patterson: trading record in brief
Matthew R. Patterson appears in our data through filings on Audentes Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 12 July 2017 to 15 January 2020, the count stands at 55 filings.
The open-market record consists of 23 sales worth €6.8M, with no purchase. The rest of the record consists of 4 share grants and 25 option exercises.
The record was last updated on 15 January 2020 with a transaction (€14.1M) in Audentes Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Matthew R. Patterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
261,458 shares@ US$60.0048.4% of flowCommon StockSEC:0001209191-20-003434:0
171,814 shares@ US$60.0031.8% of flowCommon StockSEC:0001209191-20-003434:1
74,297 shares@ US$2.190.5% of flowCommon StockSEC:0001209191-20-003110:2
11,824 shares@ US$9.500.3% of flowCommon StockSEC:0001209191-20-003110:3
11,666 shares@ US$15.260.5% of flowCommon StockSEC:0001209191-20-003110:4
12,500 shares0Common StockSEC:0001209191-20-003110:0
64,751 shares@ US$0.780.2% of flowCommon StockSEC:0001209191-20-003110:1
1,974 shares@ US$59.210.4% of flowCommon StockSEC:0001209191-19-059742:0
14,426 shares@ US$9.500.4% of flowCommon StockSEC:0001209191-19-056113:0
14,426 shares@ US$30.001.3% of flowCommon StockSEC:0001209191-19-056113:1
1,974 shares@ US$31.020.2% of flowCommon StockSEC:0001209191-19-048879:0
20,000 shares@ US$9.500.6% of flowCommon StockSEC:0001209191-19-046001:0
19,000 shares@ US$34.021.9% of flowCommon StockSEC:0001209191-19-046001:1
1,000 shares@ US$34.530.1% of flowCommon StockSEC:0001209191-19-046001:2
3,332 shares@ US$37.310.4% of flowCommon StockSEC:0001209191-19-035586:0
17,000 shares@ US$0.780.0% of flowCommon StockSEC:0001209191-19-014072:0
17,000 shares@ US$30.001.5% of flowCommon StockSEC:0001209191-19-014072:1
4,000 shares@ US$2.190.0% of flowCommon StockSEC:0001209191-19-014072:2
4,000 shares@ US$30.000.3% of flowCommon StockSEC:0001209191-19-014072:3
63,700 shares0Common StockSEC:0001209191-19-008709:0
40,000 shares@ US$0.780.1% of flowCommon StockSEC:0001209191-18-061791:0
2,144 shares@ US$0.780.0% of flowCommon StockSEC:0001209191-18-053466:0
2,144 shares@ US$39.1350.2% of flowCommon StockSEC:0001209191-18-053466:1
5,330 shares@ US$0.780.0% of flowCommon StockSEC:0001209191-18-053466:2
5,330 shares@ US$38.0360.6% of flowCommon StockSEC:0001209191-18-053466:3
25 of 55 declarations
